Metraipolis › archive › dc_ece4b44edbc3

Part II - imidazolines and rhinitis medicamentosa: how can we tackle the rebound dilemma? — Europe PMC PMID:41394157

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41394157
DOI
10.3389/fphar.2025.1655254
License (as archived)
solo-consultazione
Archived
2026-11-08T04:43:52.033Z
SHA-256 of the archived text
2af95881063f99e9840da717695d556625cf3cd9a4f714c443996b533c6c1c8b
Stable URL of this page
https://metraipolis.com/documento/dc_ece4b44edbc3

How to cite

Part II - imidazolines and rhinitis medicamentosa: how can we tackle the rebound dilemma? — Europe PMC PMID:41394157 — Europe PMC (en), https://europepmc.org/article/MED/41394157 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ece4b44edbc3 (Metraipolis archive dc_ece4b44edbc3, sha256 2af95881063f99e9840da717695d556625cf3cd9a4f714c443996b533c6c1c8b)
BibTeX
@misc{dcece4b44edbc3,
  title = {Part II - imidazolines and rhinitis medicamentosa: how can we tackle the rebound dilemma? — Europe PMC PMID:41394157},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41394157},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ece4b44edbc3; sha256 2af95881063f99e9840da717695d556625cf3cd9a4f714c443996b533c6c1c8b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41394157. Agents can read the archived copy with the MCP tool read_document.